vimarsana.com

Latest Breaking News On - Darryla leblanc - Page 1 : vimarsana.com

03 30 23 -- The Clinical Landscape Of ADCs In 2023: Diverse Technologies, Narrow Target

03/30/23 Pharmaceutical Online Newsletter

Whitney moroYves massicotteCentreone tom wilsonDarryla leblancJan vertommenPeli biothermalIwan bertholjottiAsahi kasei bioprocessJanice abelRopack pharma solutionsEvonik corporationSeeq corporationCase study syngene international ltdBernhard stumpTom ticeRopack pharma

09 22 22 -- Collaborate With Academia For Drug Discovery On Immune-Mediated Diseases

09/22/22 Pharmaceutical Online Newsletter

Jimmy beatyScott pattersonDassault systemesJurgen metzgerCharles rossChristine banaszekMatthew fergusonCameron kadleckJonathanm glynnDarryla leblancWebinar syngene international ltdSyntegon pharma technology incSon companySyntegon pharma technologyPfizer centreone small moleculeVictoria meyer

07 12 22 -- Talent Shortage In Biopharma Demands A Creative Solution

07/12/22 Pharmaceutical Online Newsletter

Matt smithFran degrazioDoug hausnerWebinar lonzaPaul priebeYiming maBryan braxtonDarryla leblancArticle syngene international ltdCase study flow sciences incServices incQosina corporationSilverson machines incPharmaceutics internationalEvonik corporationWest pharmaceutical services

Qualified Reference Standards Setting The Standard For Product Quality

Qualified reference standards play a critical role in providing validated benchmarks to satisfy regulatory requirements pertaining to purity.

Darryla leblancAnalytical servicesPrincipal scientist

Rapid Characterization Of Impurities

Understand how to manage impurities in drug development with swift isolation, synthesis, and analysis. A client discovered an impurity during ongoing.

Darryla leblancAnalytical servicesPrincipal scientist

vimarsana © 2020. All Rights Reserved.